Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-13-015860
Filing Date
2013-04-08
Accepted
2013-04-08 13:47:10
Documents
1
Period of Report
2013-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 8708
  Complete submission text file 0001140361-13-015860.txt   10628
Mailing Address 405 TRIMMER ROAD, SUITE 200 CALIFON NJ 07830
Business Address 405 TRIMMER ROAD, SUITE 200 CALIFON NJ 07830 (908) 975-0753
PediatRx Inc. (Issuer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0228
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 7TH AVENUE SW SUITE 1400 CALGARY A0 T2P 3N9
Business Address 350 7TH AVENUE SW SUITE 1400 CALGARY A0 T2P 3N9 403-538-6901
OPEX ENERGY CORP. (Reporting) CIK: 0001441607 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 13747998

Mailing Address 160 EGLINTON AVENUE EAST SUITE 602 TORONTO A6 M4P 3B5
Business Address
CARUSONE JOSEPH (Reporting) CIK: 0001449451 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 13747999